FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:690-692 August 30, 2001 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Kapiteijn, E. PubMed Citation

For a short time, the treatment of rectal cancer seemed clear and definitive. The 1990 National Institutes of Health consensus statement concluded, "Combined postoperative chemotherapy and radiation therapy improves local control and survival in stage II and III patients and is recommended."¹ At the time, the generally accepted treatment was conventional bowel resection followed by adjuvant radiation therapy (at a dose of 45 to 55 Gy) and chemotherapy if pathological findings confirmed the presence of transmural invasion or positive lymph nodes. Although the consensus statement introduced multimodal therapy as the standard treatment, results from subsequent randomized, controlled trials challenged that . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Wieder, H. A., Rosenberg, R., Lordick, F., Geinitz, H., Beer, A., Becker, K., Woertler, K., Dobritz, M., Siewert, J. R., Rummeny, E. J., Stollfuss, J. C. (2007). Rectal Cancer: MR Imaging before Neoadjuvant Chemotherapy and Radiation Therapy for Prediction of Tumor-Free Circumferential Resection Margins and Long-term Survival. Radiology 243: 744-751 [Abstract] [Full Text]  
• Wells, B. J., Stotland, P., Ko, M. A., Al-Sukhni, W., Wunder, J., Ferguson, P., Lipa, J., Last, L., Smith, A. J., Swallow, C. J. (2007). Results of an Aggressive Approach to Resection of Locally Recurrent Rectal Cancer. Ann. Surg. Oncol. 14: 390-395 [Abstract] [Full Text]  
• Aschele, C., Friso, M. L., Pucciarelli, S., Lonardi, S., Sartor, L., Fabris, G., Urso, E. D. L., Del Bianco, P., Sotti, G., Lise, M., Monfardini, S. (2005). A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann Oncol 16: 1140-1146 [Abstract] [Full Text]  
• Ghadimi, B. M., Grade, M., Difilippantonio, M. J., Varma, S., Simon, R., Montagna, C., Fuzesi, L., Langer, C., Becker, H., Liersch, T., Ried, T. (2005). Effectiveness of Gene Expression Profiling for Response Prediction of Rectal Adenocarcinomas to Preoperative Chemoradiotherapy. JCO 23: 1826-1838 [Abstract] [Full Text]  
• Beets-Tan, R. G. H., Beets, G. L. (2004). Rectal Cancer: Review with Emphasis on MR Imaging. Radiology 232: 335-346 [Abstract] [Full Text]  
• Farrugia, D. C., Ford, H. E. R., Cunningham, D., Danenberg, K. D., Danenberg, P. V., Brabender, J., McVicar, A. D., Aherne, G. W., Hardcastle, A., McCarthy, K., Jackman, A. L. (2003). Thymidylate Synthase Expression in Advanced Colorectal Cancer Predicts for Response to Raltitrexed. Clin. Cancer Res. 9: 792-801 [Abstract] [Full Text]  
• Meagher, A. P., Cornes, P. G.S., Shahidi, M., Harewood, G. C., Wiersema, M. J., Marijnen, C. A.M., Kapiteijn, E., van de Velde, C. J.H., Nelson, H., Sargent, D. J. (2002). Radiotherapy for Rectal Cancer. NEJM 346: 137-138 [Full Text]